Andere Kunden interessierten sich auch für
![Quadruplex Nucleic Acids]( "Quadruplex Nucleic Acids")
Quadruplex Nucleic Acids220,99 €![Organic Chemistry of Nucleic Acids]( "Organic Chemistry of Nucleic Acids")
Organic Chemistry of Nucleic Acids39,99 €![Organic Chemistry of Nucleic Acids]( "Organic Chemistry of Nucleic Acids")
Organic Chemistry of Nucleic Acids39,99 €![Quadruplex Nucleic Acids]( "Quadruplex Nucleic Acids")
Quadruplex Nucleic Acids220,99 €![Non-Natural Nucleic Acids]( "Non-Natural Nucleic Acids")
Non-Natural Nucleic Acids81,99 €![Quadruplex Nucleic Acids]( "Quadruplex Nucleic Acids")
Quadruplex Nucleic Acids192,99 €![Non-Natural Nucleic Acids]( "Non-Natural Nucleic Acids")
Non-Natural Nucleic Acids110,99 €
Across the world, different diseases have been
treated with herbal extracts, based on common and
empiric knowledge. The process of identification of
the active compounds and their synthesis,
optimisation and development for new drug candidates
appropriate for clinical use is described as
Medicinal Chemistry; a discipline merging chemistry
and pharmacology.
This monograph describes a group of active
ingredients from herbal medicines, as a foundation
for the development of new anticancer drugs.
Interactions between with genomic DNA, synthetic
polynucleotides and higher order DNA isoforms (triple
and quadruple helical forms) have been studied.
Rational drug design has been also employed during
this project to elucidate the mode of binding and
novel compounds have been synthesized to provide
precise structure-activity related studies resulting
in a second generation of chemotherapeutic anticancer
agents with improved properties.
This book provides information and protocols for
studying drug-DNA interactions using spectroscopical
and biological techniques; synthesis of flavonoids
and the principles to explore the use of Quantitative
Structure Activity Relationship Studies.
treated with herbal extracts, based on common and
empiric knowledge. The process of identification of
the active compounds and their synthesis,
optimisation and development for new drug candidates
appropriate for clinical use is described as
Medicinal Chemistry; a discipline merging chemistry
and pharmacology.
This monograph describes a group of active
ingredients from herbal medicines, as a foundation
for the development of new anticancer drugs.
Interactions between with genomic DNA, synthetic
polynucleotides and higher order DNA isoforms (triple
and quadruple helical forms) have been studied.
Rational drug design has been also employed during
this project to elucidate the mode of binding and
novel compounds have been synthesized to provide
precise structure-activity related studies resulting
in a second generation of chemotherapeutic anticancer
agents with improved properties.
This book provides information and protocols for
studying drug-DNA interactions using spectroscopical
and biological techniques; synthesis of flavonoids
and the principles to explore the use of Quantitative
Structure Activity Relationship Studies.